• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维肌痛患者胶原代谢改变的尿液标志物。

Urinary markers of altered collagen metabolism in fibromyalgia patients.

作者信息

Ribel-Madsen S, Christgau S, Gronemann S T, Bartels E M, Danneskiold-Samsøe B, Bliddal H

机构信息

The Parker Institute, Department of Rheumatology, Frederiksberg Hospital, Capital Region of Denmark, DK-2000 Frederiksberg, Denmark.

出版信息

Scand J Rheumatol. 2007 Nov-Dec;36(6):470-7. doi: 10.1080/03009740701483048.

DOI:10.1080/03009740701483048
PMID:18092271
Abstract

OBJECTIVE

To assess the metabolism of collagen in fibromyalgia (FM) patients, and to compare the occurrence of collagen metabolism markers to the severity of FM symptoms.

METHODS

Morning urine was collected from 27 FM women fulfilling the American College of Rheumatology (ACR) criteria for FM, and from seven controls. FM patients completed the Fibromyalgia Impact Questionnaire (FIQ). Bone mineral density (BMD), isokinetic muscle strength in knee and elbow, and hand-grip strength were measured. Urinary concentrations of collagen type I cross-linked C-telopeptide (CTX-I) and collagen type II cross-linked C-telopeptide (CTX-II) were determined by enzyme-linked immunosorbent assay (ELISA). Pyridinoline (Pyd) and deoxypyridinoline (Dpd) were determined by liquid chromatography, and hydroxyproline (Hyp) by spectrophotometry. All concentration data were normalized to creatinine.

RESULTS

Mean values in the FM group and the control group, respectively, were: urinary CTX-I 246.8 and 337.5 microg/mmol (p = 0.060); CTX-II 110.4 and 185.1 ng/mmol (p = 0.035); Pyd 56.1 and 52.3 nmol/mmol (NS); Dpd 15.1 and 14.0 nmol/mmol (NS); Pyd : Dpd ratio 4.05 and 3.96 (NS); Hyp 26.1 and 21.1 micromol/mmol (NS). Significant inverse correlations were seen between CTX-I and the intensity of fatigue, and between CTX-II and anxiety. An inverse correlation between CTX-I and muscle strength was apparent, but relied on extreme values from one patient, and no significant correlation was found between CTX-I or CTX-II and tender points or BMD in the FM group.

CONCLUSIONS

Low urinary concentrations of CTX-II and CTX-I and normal levels of Pyd and Dpd were found in FM, but their relationship to the intensity of FM symptoms was unclear.

摘要

目的

评估纤维肌痛(FM)患者的胶原蛋白代谢情况,并比较胶原蛋白代谢标志物的出现情况与FM症状严重程度。

方法

收集27名符合美国风湿病学会(ACR)FM标准的女性FM患者及7名对照者的晨尿。FM患者完成纤维肌痛影响问卷(FIQ)。测量骨密度(BMD)、膝关节和肘关节等速肌力以及握力。采用酶联免疫吸附测定(ELISA)法测定尿中I型胶原交联C端肽(CTX-I)和II型胶原交联C端肽(CTX-II)的浓度。采用液相色谱法测定吡啶啉(Pyd)和脱氧吡啶啉(Dpd),采用分光光度法测定羟脯氨酸(Hyp)。所有浓度数据均以肌酐进行标准化。

结果

FM组和对照组的平均值分别为:尿CTX-I 246.8和337.5μg/mmol(p = 0.060);CTX-II 110.4和185.1 ng/mmol(p = 0.035);Pyd 56.1和52.3 nmol/mmol(无显著性差异);Dpd 15.1和14.0 nmol/mmol(无显著性差异);Pyd:Dpd比值4.05和3.96(无显著性差异);Hyp 26.1和21.1μmol/mmol(无显著性差异)。CTX-I与疲劳强度之间以及CTX-II与焦虑之间存在显著的负相关。CTX-I与肌肉力量之间存在明显的负相关,但依赖于一名患者的极值,且在FM组中未发现CTX-I或CTX-II与压痛点或BMD之间存在显著相关性。

结论

FM患者尿中CTX-II和CTX-I浓度较低,Pyd和Dpd水平正常,但其与FM症状强度的关系尚不清楚。

相似文献

1
Urinary markers of altered collagen metabolism in fibromyalgia patients.纤维肌痛患者胶原代谢改变的尿液标志物。
Scand J Rheumatol. 2007 Nov-Dec;36(6):470-7. doi: 10.1080/03009740701483048.
2
A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.猫骨代谢血清和尿液标志物测量方法的比较。
Res Vet Sci. 2004 Aug;77(1):29-39. doi: 10.1016/j.rvsc.2004.02.007.
3
Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.健康人群、绝经后骨质疏松症和 1 型糖尿病患者的尿骨吸收标志物(脱氧吡啶啉和 I 型胶原 C 末端肽)。
Adv Med Sci. 2009;54(1):1-6. doi: 10.2478/v10039-009-0003-x.
4
Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.尿II型胶原螺旋肽(HELIX-II)作为骨关节炎和类风湿关节炎患者软骨降解的新型生化标志物。
Arthritis Rheum. 2005 Apr;52(4):1081-90. doi: 10.1002/art.20930.
5
Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.早期类风湿关节炎患者尿葡萄糖基-半乳糖基-吡啶啉和II型胶原C末端肽基线水平与关节破坏进展的相关性
Arthritis Rheum. 2002 Jan;46(1):21-30. doi: 10.1002/1529-0131(200201)46:1<21::AID-ART10061>3.0.CO;2-Q.
6
Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations.成骨不全症患者的软骨 II 型胶原蛋白降解增加,可作为骨 I 型胶原蛋白改变的人类模型。
Bone. 2010 Apr;46(4):897-900. doi: 10.1016/j.bone.2009.12.003. Epub 2009 Dec 11.
7
Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis.血清Ⅰ型胶原羧基末端肽浓度与系统性硬化症皮肤和肺部受累的相关性
J Rheumatol. 2003 Jan;30(1):68-73.
8
Urinary markers of type I collagen degradation in the dog.犬I型胶原降解的尿液标志物
Res Vet Sci. 2000 Oct;69(2):123-7. doi: 10.1053/rvsc.2000.0397.
9
Markers of bone resorption--measurement in serum, plasma or urine?骨吸收标志物——血清、血浆还是尿液中的测量?
Clin Lab. 2003;49(5-6):203-7.
10
Effect of surgical menopause and Paget's disease of bone on the isomerization of type I collagen carboxyterminal telopeptide: evolution after antiresorptive therapy.手术绝经和骨佩吉特病对I型胶原羧基末端肽异构化的影响:抗吸收治疗后的演变
J Bone Miner Metab. 2002;20(2):116-20. doi: 10.1007/s007740200016.

引用本文的文献

1
Fascial preadipocytes: another missing piece of the puzzle to understand fibromyalgia?筋膜前脂肪细胞:理解纤维肌痛的又一缺失环节?
Open Access Rheumatol. 2018 May 1;10:27-32. doi: 10.2147/OARRR.S155919. eCollection 2018.
2
Association between low bone mineral density and fibromyalgia: a meta-analysis.骨密度降低与纤维肌痛的相关性:一项荟萃分析。
Clin Rheumatol. 2017 Nov;36(11):2573-2579. doi: 10.1007/s10067-017-3683-9. Epub 2017 May 23.
3
Bone mass and vitamin D levels in women with a diagnosis of fibromyalgia.诊断为纤维肌痛的女性的骨量和维生素D水平
Osteoporos Int. 2014 Feb;25(2):525-33. doi: 10.1007/s00198-013-2434-2. Epub 2013 Sep 6.
4
Toward characterization and definition of fibromyalgia severity.走向纤维肌痛严重程度的特征化和定义。
BMC Musculoskelet Disord. 2010 Apr 8;11:66. doi: 10.1186/1471-2474-11-66.